Moreover, pre-incubation with z-DEVD-fmk, a Caspase 3 specific inhibitor, completely inhibited PT-induced increase of Caspase 3 activity and abolished PT-induced cell death in NSCLC cells. This evidence concerns the gene CASP3 and non-small cell lung carcinoma.